SLC5A2 and diabetes mellitus: To the best of our knowledge, this is the first study on the potential protective role of SGLT2-i from CI-AKI in HF patients undergoing invasive procedures with ICM, independently from the presence of diabetes, chronic kidney disease and acute coronary syndromes.